Introduction
Vertebroplasty is a popular treatment for osteoporotic vertebral compression fractures, and various preventive strategies have been introduced to reduce the number and severity of complications. Bone cement leakage and embolism can occur when a lower viscosity cement is infused through a cement filling tube with a relatively small diameter1,2. The cement that leaks into the spinal canal or neural canal can cause stenosis, and a high polymerization temperature can cause severe thermal injury to the nerve tissue3,4. In addition, the vertebral body strengthened with the cement itself might induce an adjacent vertebral compression fracture5-7. To reduce these complications from vertebroplasty, there have been several reports on the ideal mechanical properties of the cement for vertebroplasty, including methods for infusing the cement with high viscosity and the use of cement with less strength and a lower polymerization temperature8-10. The porosity generated by filler materials may allow the release of antibiotics loaded in cement more easily but their Young's modulus should be decreased. On the other hand, the cement must be beneficial in vertebroplasty and have other modified properties, including a reduced setting time due to the faster polymerization time and the lower polymerization temperature10-12. This study examined whether mixing blood into cement can make the mechanical properties more suitable to vertebroplasty to reduce the number of complications.
Materials and Methods
1. Materials and mixing methods
Exolent Spine (Elmdown Ltd., London, UK) contained 20 g (20 ml) of polymer and 9.2 g (8 ml) of monomer per one pack. The specimens were mixed in a operating room with a room temperature of 18℃ and 21% humidity with the cement preserved at room temperature for more than 24 hours. Six specimens were made in each group including the regular cement group (R) and blood-mixed groups (B2, B4, B6), which contained separately 2 ml, 4 ml, and 6 ml of blood in a single pack of cement, respectively. One researcher gave blood, which had a hemoglobin and hematocrit level of 16.7 mg/dl and 34.8%, respectively. It was sampled immediately before being mixed with the cement and should be mixed within a short time (about 1 minute after sampling) prior to hematoma formation. Cement was mixed evenly at a 2 Hz speed for approximately 45 seconds and more 15 seconds after mixing the blood. The mixed cement was transferred into a 20 ml regular syringe and filled into a stainless mold with a 10 mm inner diameter and a 30 mm height to make one block for the Young's modulus, and into three filler tubes with a 2.8 mm inner diameter and 215 mm height to measure the optimal passing-time. The cement remaining in the syringe was transferred into a bowel to measure the polymerization temperature and setting time. The cement block was easily separated by light impact with a rod after 24 hours when the cement specimen had hardened completely. The height and diameter was manipulated accurately with sandpaper and inspected with Venier Calipers (Mitutoyo, Kawasaki, Japan) with 0.05 mm accuracy. The same procedures were repeated six times to make six samples and collect the data in each group.
2. Study methods
The Young's modulus was measured using an Instron Micro-test system (Instron, Norwood, MA, USA) under a compressive speed and load of 5 mm/minutes and 2 kN, respectively. The Young's modulus was defined as the slope of the stress-strain curve. The displacement by load was measured at 20 Hz and the data collected was analyzed using Bluehill 2 software (Instron). The polymerization temperature reached a maximum after mixing the polymer and monomer, and was measured using an Infrared Thermometer (AR852B; ARCO, Guangzhou, China) under the condition of 0.9 emissivity and within 10 mm from the specimen for the optimal optic-distance ratio. The setting time was defined as the interval time from a mixing-start point to a point reaching polymerization temperature12. The optimal passing time was defined as the possible interval time for the cement with an optimal viscosity to pass through a filler tube with a inner diameter of 2.8 mm using a 20-50 N hand pushing pressure. The cement viscosity that could be passed by less than 20 N hand pressure showed more running fluid character, and the cement viscosity that could be passed with 20-50 N showed sticky, tenacious and malleable properties. The hardened cement that required more than 60 N hand pressure could not be passed through the cement filler tube and fixed to the pusher within the tube. Considering these properties as cement hardened, the optimal passing-time was determined to be the interval showing a certain viscosity equal to the 20-50 N hand pressure. The pressure passing viscous fluid through a tube was determined to be the viscosity coefficient and diameter of the tube8. A larger diameter tube has been already used for higher viscosity cement in order to allow easy passing clinically. Therefore, this study used a tube with a 2.8 mm inner diameter and 215 mm length, which is generally used for kyphoplasty. A zig was required to connect the filler tube and a digital pressure gauge, FGP-5 (NIDEC-SHIMPO Corporation, Kyoto, Japan) tightly and avoid unnecessary resistant pressure evoked by a sagged axis. The minimal pressure required to pass the cement through the tube was measured (Fig. 1). The porosity of the cement specimens was measured using SkyScan 1076 Micro-CT System (Skyscan, Aartselaar, Begium). The data was analyzed using the SPSS 15.0 (SPSS Inc., Chicago, IL, USA). The Young's modulus, polymerization temperature, setting time, optimal passing-time and porosity were compared statistically using a one-way ANOVA test to test the null hypothesis, and a Tukey's-b test with a Post Hoc multiple comparison test was used to identify differences between the groups.
Results
The Young's modulus of group R, B2, B4 and B6 was 919.5±148.2 MPa, 701.0±76.1 MPa, 693.5±104.1 MPa, and 545.6±93.1 MPa, respectively. The Young's moduli of the Blood-mixed polymethylmetacrylate (PMMA) groups were significantly lower than that of group R. The more blood-mixed PMMA showed a lower modulus but the difference between the groups was not significant according to the Post Hoc multiple comparison test (Table 1). The polymerization temperature of group R, B2, B4 and B6 was 74.2±2.6℃, 59.8±2.2℃, 54.2±1.6℃, and 47.5±1.0℃, respectively. The blood-mixed PMMA groups showed a significantly lower polymerization temperature than that of group R. In addition, the polymerization temperature and setting time decreased with increasing amount of blood.
The setting time of the group R, B2, B4 and B6 was 1065±15 seconds, 624±8 seconds, 678±3 seconds, and 606±8 seconds, respectively. The optimal passing-time of group R, B2, B4 and B6 was 75.6±2.6 seconds, 46.6±2.3 seconds, 65.0±6.1 seconds, and 79.0±4.2 seconds, respectively. The optimal passing-time increased with increasing amount of mixed blood but the setting time decreased. The optimal passing-time of B2 was almost the same as that of group R in the Post Hoc test.
The porosity of group R, B2, B4 and B6 in micro-CT was found to be 4.2±0.6%, 27.6±1.7%, 27.5±1.4% and 29.5±1.6%, respectively. The blood-mixed PMMA groups showed similar porosity regardless of the amount of mixed blood according to the Post Hoc test. Micro-CT revealed micropores distributed evenly in the blood-mixed PMMA groups (Fig. 2).
Discussion
Vertebroplasty with PMMA for osteoporotic vertebral compression fracture is considered to be very successful in that stabilization of fractured osteoporotic vertebral body and dramatic pain relief. However, with the increasing use of the procedure, many complications have been reported. One of them was adjacent vertebral compression fractures, which might be caused by outward factors including stress transferred from a treated vertebra with PMMA, poor sagittal balance and compensation of the upper body shifting after pain relief, intradiscal cement leakage, cement configuration and an infused volume in the vertebral body as well as an inward resistant factor, i.e. bone density6,7,13-17. The strength of PMMA was eight to forty times higher than that of the osteoporotic vertebra. Therefore, harder PMMA in the verterbral body could cause more stress transfer to the surrounding cancellous bone, causing continuous refracturing of a treated body or into the adjacent vertebral endplate, resulting in an additional vertebral fracture5,18. Lower modulus PMMA or PMMA substitutes are recommended to reduce the newly increasing stress transfer after vertebroplasty19,20. The optimal modulus of PMMA for vertebroplasty cannot be determined due to the combined mechanical effects of the variety of causative factors on the adjacent vertebral fractures. However, considering the strength of PMMA only, a sufficient volume of PMMA supporting both the upper and lower endplates in the vertebral body was reported to increase the level of stress transfer by 670% and 200% using 3,000 MPa and 100 MPa PMMA, respectively21. Therefore, the use of commercially available PMMA with a modulus of 1,000 MPa for verterboplasty can cause approximately 200-400% stress transfer. In addition, the modulus of osteoporotic vertebral body was considered in stress resistance. The elastic modulus of the osteoporotic vertebral body was reported to be 34 MPa, 804 MPa, and 670 MPa in cancellous bone, cortical bone and endplate, respectively22, and the early recollapse rate was reported to be 16% in vertebroplasty with lower modulus substitutes, such as calcium phosphate cement23. The optimal modulus of PMMA was the modulus near the vertebral body to prevent a treated veterbral body from refracture and reduce the increase of stress transfer. The polymer to monomer ratio was changed to reduce the modulus of PMMA by 19.5% from 2,210 MPa to 1,780 MPa, but could not reach the clinical requirements11. Fifty percent mixing with a radiopaque material could decrease the modulus by 95.7%, from 2,800 MPa to 120 MPa, but the result was also ineffective clinically because PMMA with such a low modulus could not recover the strength of a treated vertebra to the preinjured level24. These results showed that 4 ml and 6 ml blood mixed PMMA showed a modulus of 701 MPa and 545.6 MPa, respectively, which is similar to the modulus of cortical and endplate in an osteoporotic vertebral body.
The moduli and porosities of the blood-mixed PMMAs were unaffected by the volume of blood. The lack on an increase in porosity with increasing blood volume was due to the previous mixing of the polymer and monomer for 45 seconds, which might already produce a certain level of polymerization, and the mixing methods with the hands in which there could be a limitation of flourishing porosity over a certain point. The early mixing of blood and PMMA might allow considerable porosity to the blood-mixed PMMA, but more porous PMMA was not required. Overplus blood, on the other hand, which did not be mixed with PMMA, was shifted to the surface of PMMA and produced a larger plasma barrier on the PMMA specimen.
Porosity caused by the mixing of a filler can reduce the modulus of PMMA. A filler which is available in verterbroplasty to endow porosity, should have high viscosity, easy resorption and release from PMMA, water solubility, biocompatibility and biodegradability10. Boger et al.10 reported that when a pack of PMMA was mixed with sodium hyaluronate at a 35% (13 ml) volume ratio, it resulted in a 56% porosity, a decrease in modulus and polymerization temperature from 1,837 MPa to 477 MPa and from 68℃ to 41℃, respectively, which could prevent thermal injury to the surrounding soft tissues. A very small amount of sodium hyaluronate is already used in a bone substitute product. However, such a large volume of sodium hyaluronate might cause an embolism in the blood. Hence, the safety cannot be guaranteed except for topical use in those regions from which sodium hyaluronate could not be resorbed directly into the blood25.
A filler and additive mixed with PMMA can reduce the polymerization temperature. A filler might produce pores in PMMA, which can allow the polymerization heat to dissipate quickly, and an additive may induce a new polymerization reaction with a lower heat of reaction. One of the theories of pain relief by verterbroplasty was the thermal necrosis of the peripheral endings of the nerve fibers in the vertebral body. However, calcium phosphate cement with no exothermic effect can show similar pain relief. On the other hand, a microscopic study showed that micronecrosis around PMMA after verterbroplasty was due to a resorption process rather than to a foreign body reaction caused by PMMA reaction heating or radiopaque barium26,27. The central temperature of PMMA in polymerization reached 49-112℃, and the duration in which the temperature exceeded 50℃ lasted for almost 8 minutes, which might be enough to injure the nerve tissue. If PMMA with the emission of significant reaction heat leaked into the spinal canal, heat transfer could be mostly intercepted by the continuous flow of the cerebrospinal fluid (CSF), but the mass effect could provoke stenosing neurologic symptoms. However, it would cause thermal injury to the nerve tissue if it leaked into the neural foramen and bordered on a root ganglion without the flow of CSF. Therefore, the reaction heat in the polymerization of PMMA should be lower3,4,28,29. In the case of blood-mixed PMMA, the polymerization temperature was as high as 47.5-54.2℃, which is not believed to be enough to prevent thermal injury but the temperature may be decreased easily to a safe level on surrounding tissues in a shorter time than that of regular PMMA.
According to the Hagen-Poiseuille law, the pressure required in passing liquid PMMA through a filler tube is dependent on the viscosity of the PMMA in direct proportion8.
The setting time decreased in the blood-mixed PMMA, which is similar to the same results of various filler-mixed PMMAs. A decrease in setting times means that the viscosity is elevated faster and PMMA hardens earlier. Viscous PMMA should be passed through a filler tube of a smaller diameter during verterbroplasty rather than kyphoplasty. If the viscosity is elevated over a certain level and an optimal passing-point is missed, sufficient volume of PMMA could not be infused into the verterbral body and become stuck in the tube. However, the optimal passing-time of blood-mixed PMMA was lengthened in proportion to the volume of blood regardless of the shortened setting time, because of the plasma barrier formed on the surface of the PMMA specimen, which worked effectively as a lubricant between the PMMA and the tube. The optimal passing-time of group B6 was similar to that of group R but the setting time of group B6 was reduced by 43% compared to group R. Hence, the viscosity of group B6 was much higher than that of group R at the same point of infusion, which can clinically reduce the risk of extravasation from a vertebral body or an embolism of PMMA.
Micro-CT revealed micropores which were distributed evenly but not interconnected, so the PMMA and cancellous bone could not be suspected to be conglutinated in the processing of bone union.
In some point of view, bone substitutes were suspected to be replaced for PMMA even in treatment for osteoporotic vertebral compression fractures. Bone substitutes undergo a process of crystallization without an exothermic effect in the body temperature rather than polymerization. In addition, they can be resorbed by osteoclasts followed by the remodeling of host bone, and do not release toxic substances like the monomer in PMMA20,30,31. However, calcium carbonate cement was resorbed very early within two to four months after infusion, making unable to support a collapsed body for sufficient time32, and calcium phosphate cement has a risk of recollapse of the fractured vertebral body due to the very low strength23,33. Calcium sulphate cement can restore the treated vertebral strength to a similar strength through regular PMMA but it has also a risk of refracture of the treated verterbra due to the rapid resorption34,35. It is believed that the advantage of resorption and replacement of calcium phosphate cement by the normal host bone does not exactly mean the recovery of bone density and strength to those of the young and healthy vertebra that would be sufficient to prevent refracture of an osteoporotic vertebral body. In addition, the use of these substitutes carries a risk of embolism, and the disintegration tendency can deteriorate the pulmonary and arterial oxygen tension in the aqueous environment of continuous blood flow in a vertebral body in an experimental study36. Hydroxyapatite is believed to overcome the disadvantages of regular PMMA and calcium phosphate cement. However, its high viscosity can make handling and infusion more difficult and the resorption property can be obscure. Its use is not yet prevalent because of its cost effectiveness37,38.
There were several limitations in this study due to the aims of the study, which was focused on identifying the clinical problems and solutions during performing vertebroplasty, and the measurement criteria and methods were thought to be possibly affected by the subjective opinion by researchers. The optic-distance ratio must be considered when using an infrared thermometer as a noncontact measurement. The recorded temperature would have been lower than the real temperature if the temperature was measured far from the acceptable distance according to optic-distance ratio when the larger measured area was detected by a non-contact measurement method. An infrared thermometer calculates the average temperature over a certain area. The emissivity of PMMA was believed to be 0.8-0.9, which is similar to plaster or brick. Steinless showed lower emissivity. Therefore, the measured temperature would have been much lower than the real polymerization temperature if the polymerization temperature was measured on the surface of a steinless mold containing PMMA. Accordingly, more studies using similar instruments and objective methods would be done to overcome these limitations and more advisable and objective methods could be commented.
Conclusions
Blood was used as a biocompatible filler to modify the properties of bone cement to make it more suitable to vertebroplasty by reducing the Young's modulus to that of the osteoporotic vertebral body and lowering the polymerization temperature. The blood-mixed cement is believed to have clinical benefits in vertebroplasty, in that a lower modulus can reduce the level of stress to the adjacent vertebrae. In addition, the lubricant effect of the plasma membrane can allow a high viscosity cement to pass smoothly under the same pressure for passing regular cement to reduce a risk of cement leakage and embolism. Furthermore, a lower polymerization temperature might also reduce a risk of thermal injury to the nerve tissue.